Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes
© 2017 by the American Diabetes Association..
OBJECTIVE: The GERODIAB study is a multicenter prospective observational study performed over 5 years in French patients aged 70 years or above with type 2 diabetes. This report deals with their cardiovascular complications and their relationship with survival.
RESEARCH DESIGN AND METHODS: Consecutive patients (n = 987, median age = 77 years) were included from 56 diabetes centers over 1 year. Individual characteristics, history and complications of diabetes, geriatric factors, and clinical and biological parameters were recorded. Survival was analyzed using the Kaplan-Meier method and proportional hazards regression models.
RESULTS: The frequency of cardiovascular complications increased from 47% at inclusion to 67% at 5 years. The most frequent complications were coronary heart disease (increasing from 30% to 41%) and vascular disease of the lower limbs (25% to 35%) and of the cerebral vessels (15% to 26%). Heart failure was less common, but its frequency doubled during the follow-up (9% to 20%). It was strongly associated with poor survival (P < 0.0001), as was vascular disease of the lower limbs (P = 0.0004), whereas coronary heart disease (P = 0.0056) and vascular disease of cerebral vessels (P = 0.026) had mild associations. Amputation (P < 0.0001) and foot wounds (P < 0.0001) were strongly associated with survival. In multivariate models, heart failure was the strongest predictor of poor survival (hazard ratio [HR] 1.96 [95% CI 1.45-2.64]; P < 0.0001). It remained significant when other factors were considered simultaneously (HR 1.92 [95% CI 1.43-2.58]; P < 0.0001).
CONCLUSIONS: Cardiovascular complications are associated with poor survival in elderly patients with type 2 diabetes, especially heart failure.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Diabetes care - 41(2018), 1 vom: 07. Jan., Seite 156-162 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bauduceau, Bernard [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9100L32L2N |
|---|
| Anmerkungen: |
Date Completed 08.05.2018 Date Revised 07.12.2022 published: Print-Electronic ClinicalTrials.gov: NCT01282060 Citation Status MEDLINE |
|---|
| doi: |
10.2337/dc17-1437 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM277810035 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM277810035 | ||
| 003 | DE-627 | ||
| 005 | 20231225015130.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2337/dc17-1437 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0926.xml |
| 035 | |a (DE-627)NLM277810035 | ||
| 035 | |a (NLM)29113984 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bauduceau, Bernard |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.05.2018 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT01282060 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2017 by the American Diabetes Association. | ||
| 520 | |a OBJECTIVE: The GERODIAB study is a multicenter prospective observational study performed over 5 years in French patients aged 70 years or above with type 2 diabetes. This report deals with their cardiovascular complications and their relationship with survival | ||
| 520 | |a RESEARCH DESIGN AND METHODS: Consecutive patients (n = 987, median age = 77 years) were included from 56 diabetes centers over 1 year. Individual characteristics, history and complications of diabetes, geriatric factors, and clinical and biological parameters were recorded. Survival was analyzed using the Kaplan-Meier method and proportional hazards regression models | ||
| 520 | |a RESULTS: The frequency of cardiovascular complications increased from 47% at inclusion to 67% at 5 years. The most frequent complications were coronary heart disease (increasing from 30% to 41%) and vascular disease of the lower limbs (25% to 35%) and of the cerebral vessels (15% to 26%). Heart failure was less common, but its frequency doubled during the follow-up (9% to 20%). It was strongly associated with poor survival (P < 0.0001), as was vascular disease of the lower limbs (P = 0.0004), whereas coronary heart disease (P = 0.0056) and vascular disease of cerebral vessels (P = 0.026) had mild associations. Amputation (P < 0.0001) and foot wounds (P < 0.0001) were strongly associated with survival. In multivariate models, heart failure was the strongest predictor of poor survival (hazard ratio [HR] 1.96 [95% CI 1.45-2.64]; P < 0.0001). It remained significant when other factors were considered simultaneously (HR 1.92 [95% CI 1.43-2.58]; P < 0.0001) | ||
| 520 | |a CONCLUSIONS: Cardiovascular complications are associated with poor survival in elderly patients with type 2 diabetes, especially heart failure | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Observational Study | |
| 650 | 7 | |a Glycated Hemoglobin A |2 NLM | |
| 650 | 7 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |2 NLM | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 650 | 7 | |a Metformin |2 NLM | |
| 650 | 7 | |a 9100L32L2N |2 NLM | |
| 700 | 1 | |a Le Floch, Jean-Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Halimi, Serge |e verfasserin |4 aut | |
| 700 | 1 | |a Verny, Christiane |e verfasserin |4 aut | |
| 700 | 1 | |a Doucet, Jean |e verfasserin |4 aut | |
| 700 | 0 | |a SFD/SFGG Intergroup |e verfasserin |4 aut | |
| 700 | 1 | |a Affres, Hélène |e investigator |4 oth | |
| 700 | 1 | |a Alix, Michel |e investigator |4 oth | |
| 700 | 1 | |a Archambeaud, Françoise |e investigator |4 oth | |
| 700 | 1 | |a Barrou, Zina |e investigator |4 oth | |
| 700 | 1 | |a Bauduceau, Bernard |e investigator |4 oth | |
| 700 | 1 | |a Beau, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Beltran, Sonia |e investigator |4 oth | |
| 700 | 1 | |a Benoit, Christelle |e investigator |4 oth | |
| 700 | 1 | |a Beressi, Jean-Paul |e investigator |4 oth | |
| 700 | 1 | |a Berrut, Gilles |e investigator |4 oth | |
| 700 | 1 | |a Bernachon, Florence |e investigator |4 oth | |
| 700 | 1 | |a Berne, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Blaimont, Aude |e investigator |4 oth | |
| 700 | 1 | |a Blickle, Jean-Frédéric |e investigator |4 oth | |
| 700 | 1 | |a Boda-Buccino, Mireille |e investigator |4 oth | |
| 700 | 1 | |a Bohatier, Jérôme |e investigator |4 oth | |
| 700 | 1 | |a Böhme, Philip |e investigator |4 oth | |
| 700 | 1 | |a Bordier, Lyse |e investigator |4 oth | |
| 700 | 1 | |a Bouchou, Kamel |e investigator |4 oth | |
| 700 | 1 | |a Bouillet, Benjamin |e investigator |4 oth | |
| 700 | 1 | |a Bouilloud, Florence |e investigator |4 oth | |
| 700 | 1 | |a Bouix, Rolande |e investigator |4 oth | |
| 700 | 1 | |a Boulanger, Eric |e investigator |4 oth | |
| 700 | 1 | |a Bourdel-Marchasson, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Bourgon, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Bourrinet, Emmanuelle |e investigator |4 oth | |
| 700 | 1 | |a Brocker, Patrice |e investigator |4 oth | |
| 700 | 1 | |a Bruckert, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Capet, Corine |e investigator |4 oth | |
| 700 | 1 | |a Carette, Claire |e investigator |4 oth | |
| 700 | 1 | |a Cariou, Bertrand |e investigator |4 oth | |
| 700 | 1 | |a Carreau, Agnès |e investigator |4 oth | |
| 700 | 1 | |a Chaillou-Vaurie, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Chamouni, Samir |e investigator |4 oth | |
| 700 | 1 | |a Ciangura, Cécile |e investigator |4 oth | |
| 700 | 1 | |a Collet-Gaudillat, Carole |e investigator |4 oth | |
| 700 | 1 | |a Combes-Moukhovsky, Marie-Emmanuelle |e investigator |4 oth | |
| 700 | 1 | |a Constans, Thierry |e investigator |4 oth | |
| 700 | 1 | |a Cordonnier, Muriel |e investigator |4 oth | |
| 700 | 1 | |a Cuperlier, Alain |e investigator |4 oth | |
| 700 | 1 | |a Dambre, Delphine |e investigator |4 oth | |
| 700 | 1 | |a D’Avigneau, Jacques |e investigator |4 oth | |
| 700 | 1 | |a De Botton, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Degros, Vincent |e investigator |4 oth | |
| 700 | 1 | |a Delamarre-Damier, Florence |e investigator |4 oth | |
| 700 | 1 | |a Denat, Serge |e investigator |4 oth | |
| 700 | 1 | |a Desbiez, Françoise |e investigator |4 oth | |
| 700 | 1 | |a Deumier, Bernard |e investigator |4 oth | |
| 700 | 1 | |a Dorey, François |e investigator |4 oth | |
| 700 | 1 | |a Doucet, Jean |e investigator |4 oth | |
| 700 | 1 | |a Dresco, Eric |e investigator |4 oth | |
| 700 | 1 | |a Drutel, Anne |e investigator |4 oth | |
| 700 | 1 | |a De Saint Germain, Eric Du Rosel |e investigator |4 oth | |
| 700 | 1 | |a Dubois-Laforgue, Danièle |e investigator |4 oth | |
| 700 | 1 | |a Duly-Bouhanick, Béatrice |e investigator |4 oth | |
| 700 | 1 | |a Dupuy, Olivier |e investigator |4 oth | |
| 700 | 1 | |a Dusselier, Laurent |e investigator |4 oth | |
| 700 | 1 | |a Faucher-Kareche, Samir |e investigator |4 oth | |
| 700 | 1 | |a Fendri, Salha |e investigator |4 oth | |
| 700 | 1 | |a Fontaine, Pierre |e investigator |4 oth | |
| 700 | 1 | |a Galinat, Sophie |e investigator |4 oth | |
| 700 | 1 | |a Gentric, Armelle |e investigator |4 oth | |
| 700 | 1 | |a Gin, Henri |e investigator |4 oth | |
| 700 | 1 | |a Glaise, f. |e investigator |4 oth | |
| 700 | 1 | |a Godeau, Thierry |e investigator |4 oth | |
| 700 | 1 | |a Gonzalez, Béatrice |e investigator |4 oth | |
| 700 | 1 | |a Got, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Guerci, Bruno |e investigator |4 oth | |
| 700 | 1 | |a Guillausseau, Pierre-Jean |e investigator |4 oth | |
| 700 | 1 | |a Hadjadj, Samir |e investigator |4 oth | |
| 700 | 1 | |a Hadjali, Yassine |e investigator |4 oth | |
| 700 | 1 | |a Halbron, Marie |e investigator |4 oth | |
| 700 | 1 | |a Halimi, Serge |e investigator |4 oth | |
| 700 | 1 | |a Halter, Charles |e investigator |4 oth | |
| 700 | 1 | |a Hanaire, Hélène |e investigator |4 oth | |
| 700 | 1 | |a Hardy, Véronique |e investigator |4 oth | |
| 700 | 1 | |a Hartemann-Heurtier, Agnès |e investigator |4 oth | |
| 700 | 1 | |a Haulot, Jean-Pierre |e investigator |4 oth | |
| 700 | 1 | |a Hequet, Fanny |e investigator |4 oth | |
| 700 | 1 | |a Issa-Sayegh, Michel |e investigator |4 oth | |
| 700 | 1 | |a Jan, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Jeandidier, Nathalie |e investigator |4 oth | |
| 700 | 1 | |a Joseph-Henri, Hélène |e investigator |4 oth | |
| 700 | 1 | |a Julier, Ingrid |e investigator |4 oth | |
| 700 | 1 | |a Kerlan, Véronique |e investigator |4 oth | |
| 700 | 1 | |a Kharitonnoff, Tania |e investigator |4 oth | |
| 700 | 1 | |a Ladsous, Miriam |e investigator |4 oth | |
| 700 | 1 | |a Lahaxe, Laure |e investigator |4 oth | |
| 700 | 1 | |a Larmaraud, Marie-Pierre |e investigator |4 oth | |
| 700 | 1 | |a Lassenne, Elisa |e investigator |4 oth | |
| 700 | 1 | |a Lecerf, Jean-Michel |e investigator |4 oth | |
| 700 | 1 | |a Lecomte, Pierre |e investigator |4 oth | |
| 700 | 1 | |a Leroux, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Lesven, Sandra |e investigator |4 oth | |
| 700 | 1 | |a Levy, Marc |e investigator |4 oth | |
| 700 | 1 | |a Lopez, Stéphanie |e investigator |4 oth | |
| 700 | 1 | |a Matta, Maria |e investigator |4 oth | |
| 700 | 1 | |a Makiza, François |e investigator |4 oth | |
| 700 | 1 | |a Manckoundia, Patrick |e investigator |4 oth | |
| 700 | 1 | |a Marquis Pomeau, Caroline |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes care |d 1979 |g 41(2018), 1 vom: 07. Jan., Seite 156-162 |w (DE-627)NLM00042983X |x 1935-5548 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2018 |g number:1 |g day:07 |g month:01 |g pages:156-162 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2337/dc17-1437 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2018 |e 1 |b 07 |c 01 |h 156-162 | ||